siRNA therapy decreases triglycerides in people along with unusual condition

.INVESTIGATION HIGHLIGHT.19 September 2024.

Plozasiran minimized triglyceride amounts through 80% and reduced the threat of pancreatitis in patients along with consistent chylomicronemia, with or without a hereditary prognosis.